NCT04338165 Impact of PCSK9 Inhibitors on Coronary Microvascular Dysfunction in Patients With Atherosclerotic Cardiovascular Disease Proved by Myocardial Ischemia and Needing Coronarography Status UNKNOWN Phase PHASE2
NCT04271735 Pilot Study to Evaluate the Effect of Nicotinamide Riboside on Immune Activation in Psoriasis Status COMPLETED Phase NA
NCT04271280 Treatment of High and Very High riSk Dyslipidemic pAtients for the PreveNTion of CardiOvasculaR Events Status COMPLETED Phase N/A
NCT03911141 Behavioral Economic Approaches to Increase Physical Activity Among Patients With Elevated Risk for Cardiovascular Disease Status COMPLETED Phase NA
NCT03749473 Evaluation of the Novel Use of Gamification With Alternative Goal-setting Experiences Status COMPLETED Phase NA
NCT03705234 A Randomized Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Cardiovascular Disease Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03597412 Rosuvastatin/Ezetimibe Versus Rosuvastatin in ASCVD Patients With Type 2 DM Status COMPLETED Phase PHASE4
NCT03505073 Association Between Dietary Habits and Risk Factors for Atherosclerotic Cardiovascular Diseases in Assiut Governorate Status UNKNOWN Phase N/A
NCT03403556 High-intensity Rosuvastatin vs. Moderate-intensity Rosuvastatin/Ezetimibe in High Atherosclerotic Cardiovascular Disease Risk Patients With Type 2 Diabetes Status UNKNOWN Phase PHASE4
NCT03096288 Impact of Evolocumab on the Effects of Clopidogrel in Patients With High On-Treatment Platelet Reactivity Status COMPLETED Phase PHASE4
NCT03067441 Assessment of the Long-Term Safety and Efficacy of Bempedoic Acid (CLEAR Harmony OLE) Status COMPLETED Phase PHASE3
NCT03060577 An Extension Trial of Inclisiran in Participants With Cardiovascular Disease and High Cholesterol Status COMPLETED Phase PHASE2
NCT02991118 Evaluation of Long-Term Efficacy of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia at High Cardiovascular Risk Status COMPLETED Phase PHASE3
NCT02988115 Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia and Statin Intolerant Status COMPLETED Phase PHASE3